Spotlight on Small Tumors
|
Nanology Labs is a pharmaceutical company that harnesses advanced nanotechnology to detect and treat cancers at the early stages
|
Nanology Labs' Platform Technology
Nanology Labs state-of-the-art platform technology TERP enables active transportation of diagnostic and therapeutic agents/molecules to the brain tumor tissue. Blood-brain-barrier (BBB) is a formidable barrier that blocks brain entry of most of drugs and imaging agents. TERP can cross intact BBB system offering access to brain tumor tissues at early stages.
MRI-Guided Radiation Therapy
Nanology Labs' smart nano-structure agent enable simultaneous MRI detection and radiation sensitization. Manganescan is an agent with tumor-selective reactivity that enables sensitive detection of tumors at early stages using MRI. At the same time, it can sensitize the tumor to radiation therapy by modifying the tumor environment, leading to significant improvement of life expectancy of cancer patients.
|
|
Interested in Partnership?
Nanology Labs aims to form strategic partnership pharmaceutical companies and researchers in the cancer diagnosis and therapy industry.
DROP US A LINE
We are actively seeking for investors, partnership and other opportunities.
|
|
ma.amini@nanologylabs.com
|
Phone |
647-447-7449
|
Address |
Room 1102, 144 College St, Toronto, ON M5S 3M2, Canada
|
